Trials / Conditions / Proliferative Vitreoretinopathy

Proliferative Vitreoretinopathy

28 registered clinical trials studyying Proliferative Vitreoretinopathy — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	The Safety and Efficacy of Intravitreal Topotecan for the Treatment of Proliferative Vitreoretinopathy NCT06425419	Massachusetts Eye and Ear Infirmary	Phase 1
Not Yet Recruiting	Study of Imaging and Molecular Biomarkers in Uncomplicated Rhegmatogenous Retinal Detachment NCT07386678	University College, London	—
Not Yet Recruiting	Intravitreal Topotecan for Prevention or Treatment of Proliferative Vitreoretinopathy in Retinal Detachment NCT06818721	Unity Health Toronto	Phase 2
Recruiting	Topical Netarsudil for the Prevention of Proliferative Vitreoretinopathy in Patients With Retinal Detachment NCT06033703	Massachusetts Eye and Ear Infirmary	Phase 1 / Phase 2
Unknown	"Comparing Methotrexate Usage Techniques to Prevent Proliferative Vitreoretinopaty After Retinal Detachment Vi NCT06289205	University of Health Sciences Lahore	Phase 1 / Phase 2
Recruiting	Prevention of ProliFerative Vitreoretinopathy with Intravitreal MethotreXate in Primary Retinal DEtachment Rep NCT06541574	Cincinnati Eye Institute, Southwest Ohio	Phase 2
Active Not Recruiting	A Multi-Center Study on the Use of Rho-Kinase Inhibitor to Reduce or Prevent PVR in RRD Eyes at High Risk for NCT05660447	Wills Eye	Phase 2 / Phase 3
Unknown	Air Versus Gas Tamponade in Primary Retinal Detachment NCT05561569	Benha University	N/A
Not Yet Recruiting	Internal Limiting Membrane Peeling in Retinal Detachment Surgery NCT05538156	Central Hospital, Nancy, France	N/A
Completed	Intravitreal Infliximab for Proliferative Vitreoretinopathy NCT04891991	Cairo University	Phase 2
Completed	Efficacy of 5-fluorouracil and Low Molecular Weight Heparin in High-risk Pediatric Retinal Detachment NCT06166914	Alexandria University	N/A
Completed	Effects of 0.1% Nepafenac on Vitreous Inflammatory Biomarkers in Rhegmatogenous Retinal Detachment and Prolife NCT07162818	Indonesia University	Phase 4
Withdrawn	Methotrexate For The Prevention and Treatment of Proliferative Vitreoretinopathy in Pediatric Patients NCT04830878	Stanford University	Phase 1
Unknown	Molecular Taxonomy of Surgically-harvested Ocular Tissues Defined by Single-cell Transcriptomics NCT04682054	The First Affiliated Hospital with Nanjing Medical University	N/A
Unknown	Intravitreal Aflibercept for the Prevention of Proliferative Vitreoretinopathy Following Retinal Detachment Re NCT04580147	M. Ali Khan, MD	Phase 2
Unknown	Repeated Methotrexate for Proliferative Vitreoretinopathy Grade C NCT04482543	Shahid Beheshti University of Medical Sciences	Phase 2 / Phase 3
Completed	Outcomes of Extensive Brilliant Blue G-Assisted Internal Limiting Membrane Peeling in Proliferative Vitreoreti NCT04490876	Centro Oftalmológico Dr Charles	—
Completed	The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy NCT04136366	Aldeyra Therapeutics, Inc.	Phase 3
Completed	Adrenocorticotropic Hormone (ACTH) for Post-op Inflammation in Proliferative Vitreoretinopathy (PVR) NCT03727776	Johns Hopkins University	EARLY_Phase 1
Unknown	Optical Coherence Tomography - Rescan During Dissection of Macular Membranes NCT02748421	Federal University of São Paulo	N/A
Completed	Bevacizumab Against Recurrent Retinal Detachment NCT02192970	University of Wisconsin, Madison	Phase 2
Completed	Postoperative Pain Control Following Vitreoretinal Surgery NCT01995045	Emory University	Phase 4
Completed	Isotretinoin for Proliferative Vitreoretinopathy NCT01445028	Wills Eye	Phase 4
Completed	Comparative Study of 1000 Centistoke Versus 5000 Centistoke Silicone Oil for Repair of Complex Retinal Detachm NCT01255293	Mid Atlantic Retina	N/A
Unknown	Oral Colchicine Combined With Intravitreal Infusion of Dexamethasone, LMW Heparin and 5-FU for Management of P NCT00370760	Shahid Beheshti University of Medical Sciences	Phase 3
Unknown	The Effect of 5-FU and LMW Heparin on the Rate of Retinal Redetachment After Silicone Oil Removal in Cases of NCT00371020	Shahid Beheshti University of Medical Sciences	Phase 3
Completed	Triamcinolone Acetonide in Silicone-Filled Eyes as Adjunctive Treatment for Proliferative Vitreoretinopathy NCT00373282	Shahid Beheshti University of Medical Sciences	Phase 3
Completed	The Silicone Study NCT00000140	National Eye Institute (NEI)	Phase 3